This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Semler Scientific（SMLR）株式概要
セムラーサイエンティフィック社は、米国の医療従事者の臨床効果と効率を高める技術ソリューションを提供しています。 詳細
SMLR Community Fair Values
Create NarrativeSee what 22 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Semler Scientific, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$20.33 |
| 52週高値 | US$65.98 |
| 52週安値 | US$14.89 |
| ベータ | 1.32 |
| 1ヶ月の変化 | 13.39% |
| 3ヶ月変化 | -9.76% |
| 1年変化 | -68.69% |
| 3年間の変化 | -45.31% |
| 5年間の変化 | -77.41% |
| IPOからの変化 | 190.84% |
最新ニュース
ナラティブの更新 • Jan 25
SMLR: All Stock Strive Deal Will Unlock Bitcoin Treasury Upside
Analysts have reaffirmed their fair value estimate for Semler Scientific at US$86.00, highlighting adjusted assumptions around the discount rate, revenue trends and profit margin, along with a lower but still very large future P/E expectation as the key drivers behind holding the target steady. What's in the News Strive, Inc.
ナラティブの更新 • Jan 08
SMLR: Future Profits And January Meeting Will Support Bullish Thesis
Analysts have reduced their price target on Semler Scientific from US$60.00 to US$51.00, citing softer revenue growth assumptions, a higher discount rate, and a very large future P/E multiple, even as projected profit margins edge slightly higher. What's in the News Semler Scientific has scheduled a special or extraordinary shareholders meeting for January 13, 2026, giving investors a date to watch for company level decisions or approvals that require shareholder input (Key Developments).Recent updates
ナラティブの更新 • Jan 25
SMLR: All Stock Strive Deal Will Unlock Bitcoin Treasury Upside
Analysts have reaffirmed their fair value estimate for Semler Scientific at US$86.00, highlighting adjusted assumptions around the discount rate, revenue trends and profit margin, along with a lower but still very large future P/E expectation as the key drivers behind holding the target steady. What's in the News Strive, Inc.ナラティブの更新 • Jan 08
SMLR: Future Profits And January Meeting Will Support Bullish Thesis
Analysts have reduced their price target on Semler Scientific from US$60.00 to US$51.00, citing softer revenue growth assumptions, a higher discount rate, and a very large future P/E multiple, even as projected profit margins edge slightly higher. What's in the News Semler Scientific has scheduled a special or extraordinary shareholders meeting for January 13, 2026, giving investors a date to watch for company level decisions or approvals that require shareholder input (Key Developments).ナラティブの更新 • Dec 18
SMLR: All Stock Acquisition Will Unlock Bitcoin Treasury Upside
Analysts have reduced their price target on Semler Scientific to $86 from $101, citing lower revenue and margin forecasts, as well as uncertainty and opportunity created by the recent all stock acquisition agreement and legal settlement. Analyst Commentary Bullish analysts acknowledge the reduced price targets but continue to frame the all stock acquisition and legal settlement as catalysts that could unlock value for Semler Scientific over the medium term.
ナラティブの更新 • Dec 04
SMLR: Shares Will Rise As All Stock Acquisition Drives Bitcoin Treasury Consolidation
Analysts have trimmed their average price target for Semler Scientific by about $15 to roughly $83 per share, citing reduced revenue expectations following updated management guidance and the implications of the recent DOJ settlement. They continue to view the stock as an attractive opportunity in light of the pending all stock acquisition by Strive and consolidation prospects in the corporate bitcoin treasury space.ナラティブの更新 • Nov 20
SMLR: Shares Will Reflect Upside As $1.4 Billion Acquisition Advances
Analysts have lowered their fair value estimate for Semler Scientific by approximately $10. This change is due to reduced revenue growth projections and updated guidance in light of recent acquisition and settlement developments.ナラティブの更新 • Sep 24
Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks
Analysts have lowered their price target for Semler Scientific from $85.33 to $75.33, citing reduced revenue forecasts following cautious management guidance, weighing of recent legal settlements, and uncertainty around the company’s pivot to a bitcoin treasury strategy despite some bullish views on its potential long-term re-rating. Analyst Commentary Bullish analysts see the acquisition by Strive (ASST) as triggering potential consolidation in the corporate bitcoin treasury sector, presenting a timely opportunity despite market uncertainty around the transaction’s longer-term implications.分析記事 • Aug 21
Is Semler Scientific (NASDAQ:SMLR) Using Too Much Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...新しいナラティブ • Aug 10
Cardiac And Digital Health Expansion Will Encounter Bitcoin Risks
Diversification into cardiac disease markets and value-based care tools positions the company for higher recurring revenues and improved long-term margins.分析記事 • Jul 09
Semler Scientific, Inc.'s (NASDAQ:SMLR) 26% Share Price Surge Not Quite Adding Up
Semler Scientific, Inc. ( NASDAQ:SMLR ) shares have had a really impressive month, gaining 26% after a shaky period...Seeking Alpha • May 29
Semler Scientific: Not The Ideal Bitcoin Treasury Company
Summary Semler Scientific's pivot to a Bitcoin treasury strategy has been successful. However, competition in the Bitcoin Treasury company space is heating up, including many well funded competitors. Declining revenues and free cash flow in its healthcare business are concerning, and Bitcoin is materially outperforming the Company year to date. Read the full article on Seeking Alpha分析記事 • May 17
Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues
Semler Scientific, Inc. ( NASDAQ:SMLR ) shareholders are no doubt pleased to see that the share price has bounced 32...分析記事 • Mar 25
Here's Why We Think Semler Scientific (NASDAQ:SMLR) Might Deserve Your Attention Today
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...分析記事 • Mar 07
Semler Scientific's (NASDAQ:SMLR) Profits May Not Reveal Underlying Issues
The recent earnings posted by Semler Scientific, Inc. ( NASDAQ:SMLR ) were solid, but the stock didn't move as much as...分析記事 • Mar 04
Semler Scientific, Inc. (NASDAQ:SMLR) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Unfortunately for some shareholders, the Semler Scientific, Inc. ( NASDAQ:SMLR ) share price has dived 25% in the last...分析記事 • Jan 15
Semler Scientific, Inc. (NASDAQ:SMLR) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Semler Scientific, Inc. ( NASDAQ:SMLR ) shares have retraced a considerable 26% in the last month, reversing a fair...株主還元
| SMLR | US Medical Equipment | US 市場 | |
|---|---|---|---|
| 7D | -0.05% | 6.1% | -3.3% |
| 1Y | -68.7% | -19.2% | 22.3% |
業界別リターン: SMLR過去 1 年間で-19.2 % の収益を上げたUS Medical Equipment業界を下回りました。
リターン対市場: SMLRは、過去 1 年間で22.3 % のリターンを上げたUS市場を下回りました。
価格変動
| SMLR volatility | |
|---|---|
| SMLR Average Weekly Movement | 18.6% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
安定した株価: SMLRの株価は、 US市場と比較して過去 3 か月間で変動しています。
時間の経過による変動: SMLRの weekly volatility ( 19% ) は過去 1 年間安定していますが、依然としてUSの株式の 75% よりも高くなっています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 2007 | 79 | Doug Murphy-Chutorian | www.semlerscientific.com |
セムラーサイエンティフィック社は、米国で医療従事者の臨床効果と効率を高める技術ソリューションを提供している。同社の製品には、医療従事者が患者の血管状態の検査の一環として血流測定を利用できるようにする、4分間の院内血流検査QuantaFloなどがある。同社の製品は、循環器専門医、内科医、腎臓専門医、内分泌専門医、足病専門医、かかりつけ医、医療保険プラン、統合医療提供ネットワーク、独立系医師グループ、リスク評価グループや小売業者など医療業界と契約している企業向けに販売されている。販売代理店やディストリビューターを通じて製品を提供している。2007年に法人化され、カリフォルニア州サンタクララに本社を置いている。
Semler Scientific, Inc. 基礎のまとめ
| SMLR 基礎統計学 | |
|---|---|
| 時価総額 | US$310.75m |
| 収益（TTM） | US$48.34m |
| 売上高(TTM) | US$36.96m |
6.4x
PER（株価収益率8.4x
P/SレシオSMLR は割高か？
公正価値と評価分析を参照収益と収入
| SMLR 損益計算書（TTM） | |
|---|---|
| 収益 | US$36.96m |
| 売上原価 | US$3.41m |
| 売上総利益 | US$33.54m |
| その他の費用 | -US$14.80m |
| 収益 | US$48.34m |
直近の収益報告
Sep 30, 2025
次回決算日
該当なし
| 一株当たり利益（EPS） | 3.16 |
| グロス・マージン | 90.76% |
| 純利益率 | 130.80% |
| 有利子負債／自己資本比率 | 25.3% |
SMLR の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/01/20 06:46 |
| 終値 | 2026/01/15 00:00 |
| 収益 | 2025/09/30 |
| 年間収益 | 2024/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
Semler Scientific, Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3
| アナリスト | 機関 |
|---|---|
| Mark Palmer | Benchmark Company |
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Brett Knoblauch | Cantor Fitzgerald & Co. |